4
Changes in Ownership
RELMADA THERAPEUTICS, INC. Filed Acc 0001213900-21-005451
CFO sold 3,000 shares at an average $31.93 ($95,778)
- CFO acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Shenouda Maged · CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 1 in the form | +3,000 | $3.24 | $9,720 | 5,228 | D |
| 2021-01-27 | Sale : show line 2 in the form | −1,800 | $31.59 | $56,862 | 3,428 | D |
| 2021-01-27 | Sale : show line 3 in the form | −1,200 | $32.43 | $38,916 | 2,228 | D |
| Open-market sales · 3,000 sh · avg $31.93 · $95,778 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-27 | Exercise or conversion : show line 4 in the form Options to purchase common stock | −3,000 | 99,250 | D |
Loading xslF345X03/ownership.xml…